FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800931582> ?p ?o ?g. }

• W2800931582 abstract "Colorectal cancer (CRC) is one of the major types of cancer and causes of mortality worldwide, and it remains the third most common cause of cancer‑associated mortality worldwide. MicroRNAs (miRNAs) are a class of small RNAs, which have been shown to be associated with CRC. In the present study, an MTT assay and proliferating cell nuclear antigen (PCNA) protein examination assay were performed to detect RKO cell viability. Hoechst staining, and caspase‑3 activity and BrdU incorporation assays were performed to detect RKO cell apoptosis, respectively. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analyses were used to analyze the expression of cyclooxygenase‑2 (COX‑2). Western blot analysis was also used to analyze the expression of vascular endothelial growth factor (VEGF) and mitogen‑activated protein kinase (MAPK) signal molecules, including extracellular signal‑regulated kinase (ERK), p38 and c‑Jun N‑terminal kinase (JNK). The target genes of miR-125 were predicted using a double luciferase reporter gene assay. The results of the MTT assay showed that RKO cell viability was decreased by an miRNA-125 mimic and increased by the miRNA-125 inhibitor. The RKO cell viability was significantly correlated with the expression of PCNA. The migration of RKO cells was significantly downregulated in the miR-125 mimics‑transfected cells and upregulated in the miRNA-125 inhibitor‑transfected cells. The results of Hoechst staining and the caspase‑3 activity and BrdU incorporation assays showed that RKO cell apoptosis was increased following miRNA-125 mimic transfection and decreased following miRNA-125 inhibitor transfection. The results of the RT‑qPCR and western blot analysis showed that the expression of COX‑2 was increased in the miR-125 mimic‑transfected cells and decreased in the miR-125 inhibitor‑transfected cells. Using an online miRNA target prediction database, the double luciferase reporter gene assay showed that miR‑125 targeted and inhibited the expression of VEGF through target sites located in the 3' untranslated region of VEGF mRNA. In conclusion, the abnormal expression of miR‑125 was found to be closely associated with CRC. Therefore, miR‑125 may be a novel therapeutic target for CRC." @default.
• W2800931582 created "2018-05-17" @default.
• W2800931582 creator A5032044163 @default.
• W2800931582 creator A5048560253 @default.
• W2800931582 creator A5050318652 @default.
• W2800931582 creator A5053636404 @default.
• W2800931582 creator A5056242959 @default.
• W2800931582 creator A5056573377 @default.
• W2800931582 creator A5072063457 @default.
• W2800931582 date "2018-04-18" @default.
• W2800931582 modified "2023-09-29" @default.
• W2800931582 title "MicroRNA‑125 inhibits RKO colorectal cancer cell growth by targeting VEGF" @default.
• W2800931582 cites W144423133 @default.
• W2800931582 cites W1781739971 @default.
• W2800931582 cites W1813804250 @default.
• W2800931582 cites W1968008181 @default.
• W2800931582 cites W1971806005 @default.
• W2800931582 cites W1972434476 @default.
• W2800931582 cites W1975167804 @default.
• W2800931582 cites W1979853723 @default.
• W2800931582 cites W1986673875 @default.
• W2800931582 cites W1988389975 @default.
• W2800931582 cites W1989454102 @default.
• W2800931582 cites W2004163835 @default.
• W2800931582 cites W2004462371 @default.
• W2800931582 cites W2010461414 @default.
• W2800931582 cites W2016112105 @default.
• W2800931582 cites W2018387247 @default.
• W2800931582 cites W2038940805 @default.
• W2800931582 cites W2045228008 @default.
• W2800931582 cites W2045886554 @default.
• W2800931582 cites W2047717400 @default.
• W2800931582 cites W2048254997 @default.
• W2800931582 cites W2069540657 @default.
• W2800931582 cites W2099169447 @default.
• W2800931582 cites W2104576980 @default.
• W2800931582 cites W2106666507 @default.
• W2800931582 cites W2107277218 @default.
• W2800931582 cites W2111792559 @default.
• W2800931582 cites W2113123857 @default.
• W2800931582 cites W2114047398 @default.
• W2800931582 cites W2116304851 @default.
• W2800931582 cites W2142221925 @default.
• W2800931582 cites W2144038313 @default.
• W2800931582 cites W2146492114 @default.
• W2800931582 cites W2147297736 @default.
• W2800931582 cites W2162289930 @default.
• W2800931582 cites W2162674813 @default.
• W2800931582 cites W2175928272 @default.
• W2800931582 cites W2309641507 @default.
• W2800931582 doi "https://doi.org/10.3892/ijmm.2018.3632" @default.
• W2800931582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29693153" @default.
• W2800931582 hasPublicationYear "2018" @default.
• W2800931582 type Work @default.
• W2800931582 sameAs 2800931582 @default.
• W2800931582 citedByCount "18" @default.
• W2800931582 countsByYear W28009315822019 @default.
• W2800931582 countsByYear W28009315822020 @default.
• W2800931582 countsByYear W28009315822021 @default.
• W2800931582 countsByYear W28009315822022 @default.
• W2800931582 countsByYear W28009315822023 @default.
• W2800931582 crossrefType "journal-article" @default.
• W2800931582 hasAuthorship W2800931582A5032044163 @default.
• W2800931582 hasAuthorship W2800931582A5048560253 @default.
• W2800931582 hasAuthorship W2800931582A5050318652 @default.
• W2800931582 hasAuthorship W2800931582A5053636404 @default.
• W2800931582 hasAuthorship W2800931582A5056242959 @default.
• W2800931582 hasAuthorship W2800931582A5056573377 @default.
• W2800931582 hasAuthorship W2800931582A5072063457 @default.
• W2800931582 hasBestOaLocation W28009315821 @default.
• W2800931582 hasConcept C104317684 @default.
• W2800931582 hasConcept C145059251 @default.
• W2800931582 hasConcept C153911025 @default.
• W2800931582 hasConcept C167734588 @default.
• W2800931582 hasConcept C184235292 @default.
• W2800931582 hasConcept C190283241 @default.
• W2800931582 hasConcept C2777025900 @default.
• W2800931582 hasConcept C2780783641 @default.
• W2800931582 hasConcept C2781018059 @default.
• W2800931582 hasConcept C29537977 @default.
• W2800931582 hasConcept C502942594 @default.
• W2800931582 hasConcept C53227056 @default.
• W2800931582 hasConcept C54009773 @default.
• W2800931582 hasConcept C54355233 @default.
• W2800931582 hasConcept C55493867 @default.
• W2800931582 hasConcept C57074206 @default.
• W2800931582 hasConcept C62112901 @default.
• W2800931582 hasConcept C81885089 @default.
• W2800931582 hasConcept C86803240 @default.
• W2800931582 hasConcept C95444343 @default.
• W2800931582 hasConceptScore W2800931582C104317684 @default.
• W2800931582 hasConceptScore W2800931582C145059251 @default.
• W2800931582 hasConceptScore W2800931582C153911025 @default.
• W2800931582 hasConceptScore W2800931582C167734588 @default.
• W2800931582 hasConceptScore W2800931582C184235292 @default.
• W2800931582 hasConceptScore W2800931582C190283241 @default.
• W2800931582 hasConceptScore W2800931582C2777025900 @default.
• W2800931582 hasConceptScore W2800931582C2780783641 @default.
• W2800931582 hasConceptScore W2800931582C2781018059 @default.
• W2800931582 hasConceptScore W2800931582C29537977 @default.

• next